Onset of acute myocardial infarction after use of non‐steroidal anti‐inflammatory drugs

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pharmacoepidemiology and Drug Safety

• Publication date

  2008-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pds.1560PMID 18302311
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of First- and Second-Generation Cyclooxygenase-2–Selective Nonsteroidal Antiinflammatory Drugs and Risk of Acute Myocardial Infarction

  2006cited by this paper
• Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction.

  2006cited by this paper
• Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs.

  2006cited by this paper
• Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

  2006cited by this paper
• Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

  2006cited by this paper
• Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors

  2006cited by this paper
• Nonsteroidal Antiinflammatory Drugs and Acute Myocardial Infarction in Patients with No Major Risk Factors

  2006cited by this paper
• Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis.

  2006cited by this paper
• Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

  2005cited by this paper
• Current Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Acute Myocardial Infarction

  2005cited by this paper
• Adjusting for Unmeasured Confounders in Pharmacoepidemiologic Claims Data Using External Information: The Example of COX2 Inhibitors and Myocardial Infarction

  2005cited by this paper
• Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.

  2005cited by this paper
• Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

  2005cited by this paper
• COX 2 inhibitors, traditional NSAIDs, and the heart

  2005cited by this paper
• Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.

  2005cited by this paper
• Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

  2005cited by this paper
• Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population

  2005cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.

  2005cited by this paper
• The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin.

  2004cited by this paper
• Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General Population

  2004cited by this paper
• Risk of cardiovascular events and rofecoxib: cumulative meta-analysis.

  2004cited by this paper
• Relationship Between Selective Cyclooxygenase-2 Inhibitors and Acute Myocardial Infarction in Older Adults

  2004cited by this paper
• Do Some Inhibitors of COX-2 Increase the Risk of Thromboembolic Events?

  2004cited by this paper
• Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly.

  2003cited by this paper
• Evaluating medication effects outside of clinical trials: new-user designs.

  2003cited by this paper
• COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease.

  2002cited by this paper
• Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction.

  2002cited by this paper
• Revitalizing the General Practice Research Database: plans, challenges, and opportunities

  2001cited by this paper
• The Risk of Gastrointestinal Bleed, Myocardial Infarction, and Newly Diagnosed Hypertension in Users of Meloxicam, Diclofenac, Naproxen, and Piroxicam

  2000cited by this paper
• The General Practice Research Database: quality of morbidity data.

  1997cited by this paper
• Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research.

  1994cited by this paper
• Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research.

  1994cited by this paper
• Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.

  1991cited by this paper
• The Robust Inference for the Cox Proportional Hazards Model

  1989cited by this paper

• Exploring the scientific underpinnings of investigating safety signals: analytical insights in deciphering drug safety evidence

  2024cites this paper
• Efficacy of S-Flurbiprofen Plaster for Analgesia Following Total Hip Arthroplasty

  2024cites this paper
• Navigating a transforming landscape: the evolving role of pharmacovigilance physicians in drug development and implications for future challenges and training requirements

  2023cites this paper
• Non-steroidal anti-inflammatory drugs and risk of myocardial infarction adjusting for use of proton pump-inhibitors in patients with no major risk factors: a nested case-control study in the UK Clinical Practice Research Datalink.

  2022cites this paper
• Personalized benefit‐risk assessments combining clinical trial and real‐world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy

  2019cites this paper
• Type 2 diabetes mellitus and gastrointestinal cancer : Disease, drugs, or distortion?

  2019cites this paper
• 1 Long-Term Treatment of Osteoarthritis Pain : Achieving a Balance Between Efficacy and Tolerability for a Successful Chronic Therapy Mila

  2017cites this paper
• Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?

  2017cites this paper
• Acute Respiratory Infection and Use of Nonsteroidal Anti-Inflammatory Drugs on Risk of Acute Myocardial Infarction: A Nationwide Case-Crossover Study

  2017cites this paper
• Acute myocardial infarction with oral nonsteroidal anti-inflammatory drugs in real-world use

  2016cites this paper
• Evidence Synthesis and Meta-Analysis for Drug Safety

  2016cites this paper
• Comparability of the age and sex distribution of the UK Clinical Practice Research Datalink and the total Dutch population

  2016cites this paper
• Adverse Drug Reactions Attributed to Ibuprofen

  2015cites this paper
• Using electronic health records to investigate blood biomarkers and onset of cardiovascular diseases: example of differential white cell count

  2015cites this paper
• Increased Risk of Subsequent Myocardial Infarction in Patients With Type 2 Diabetes: A Retrospective Cohort Study Using the U.K. General Practice Research Database

  2014cites this paper
• Assessment of nonsteroidal anti-inflammatory drug-induced cardiotoxicity

  2014influential citation
• Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies

  2013cites this paper
• Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study

  2013cites this paper
• Gender, smoking and blood pressure and the initial presentation of a wide range of cardiovascular diseases : prospective cohort study in 1.5 million patients using linked electronic health records

  2013cites this paper
• OP0200-PC Step-Up: An Innovative Stepped-Care Protocol for Tailored Behavioral Medicine Treatment in the Management of Musculoskeletal Pain in Primary Care

  2013cites this paper
• OP0203-PC New Data, New Problem; Assessing the Prevalence of Nsaid Prescribing in Primary Care in Those with a Background of Ischaemic Heart Disease (IHD) or Risk Factors for IHD

  2013cites this paper
• Quality of interaction database management systems

  2012cites this paper
• Long-Term Treatment of Osteoarthritis Pain: Achieving a Balance Between Efficacy and Tolerability for a Successful Chronic Therapy

  2012cites this paper
• Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence

  2012cites this paper
• Cardiovascular events and survival in rheumatoid arthritis: effects of anti-tumor necrosis factor-alpha treatment.

  2011cites this paper
• Risk of ST versus non-ST elevation myocardial infarction associated with non-steroidal anti-inflammatory drugs

  2011cites this paper
• Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction: A Nationwide Cohort Study

  2011cites this paper
• Health Services and Outcomes Research Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction

  2011cites this paper
• Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis.

  2010cites this paper
• Update von 10 Empfehlungen zur Therapie mit NSAR

  2010cites this paper
• Population impact of regulatory activity restricting prescribing of COX-2 inhibitors: ecological study.

  2009cites this paper
• Role of T cells in nonimmediate allergic drug reactions

  2009cites this paper
• Calidad estructural de las bases de datos de interacciones

  2009cites this paper
• Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database

  2008influential citation
• Current awareness: Pharmacoepidemiology and drug safety

  2008cites this paper